IE
ONCY

Israel Englander’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Israel Englander’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-50,000
Closed -$91K – 4208
2014
Q1 		$91K Hold
50,000
– – ﹤0.01% 3317
2013
Q4 		$78K Sell
50,000
-31,097
-38% -$70.1K ﹤0.01% 3356
2013
Q3 		$198K Buy
+81,097
New +$224K ﹤0.01% 3111

Other funds holding ONCY

1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $62.7B AUM 37.65% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Israel Englander's ONCY Position: Q2 2014 in Review

Israel Englander sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q2 2014, closing a stake of 50,000 shares — an estimated $91K sold.

Israel Englander first reported a position in ONCY in Q3 2013 and held it in 3 quarters. The position peaked at $198K in Q3 2013. 34 funds tracked by Wall St. Rank hold ONCY as of Q2 2014.

  • Israel Englander reported no remaining ONCOLYTICS BIOTECH INC position as of Q2 2014 after selling out during the quarter.
  • Israel Englander sold 50,000 ONCOLYTICS BIOTECH INC shares in Q2 2014, an estimated $91K.
  • Israel Englander first reported a position in ONCOLYTICS BIOTECH INC in Q3 2013 and held it in 3 quarters.
  • Israel Englander's ONCOLYTICS BIOTECH INC position peaked at $198K in Q3 2013.
  • 34 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q2 2014.

Based on Millennium Management's 13F filing for Q2 2014, filed 14 Aug 2014.